Ivermectin: Potential Role as Repurposed Drug for COVID-19
Brief Communications
[키워드] 2019 novel coronavirus
2019-nCoV
acute respiratory illness
acute respiratory syndrome
antibody
antiparasitic
approach
being
caused
communicable
coronavirus
coronavirus disease
Coronavirus disease 2019
country
COVID-19
develop
disease
drug
Drug repurposing
effective
effort
information
Ivermectin
lack
pandemic
Pathogenesis
pathway
Potential
proliferation
rapid response
Repurposed drug
role
SARS-CoV-2
spread to
the disease
therapeutic
therapeutic agents
therapeutic drug
therapeutic option
this new coronavirus
Treatment
Vaccine
virus
WHO
World Health Organization
[DOI] 10.21315/mjms2020.27.4.15 PMC 바로가기 [Article Type] Brief Communications
[DOI] 10.21315/mjms2020.27.4.15 PMC 바로가기 [Article Type] Brief Communications